Source: Clinical Chemistry and Laboratory Medicine. Conference titles: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
ABNT
ARAZI, Simone Sorkin et al. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 23 abr. 2024. , 2008APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Nakandakare, E. R., Neves, M. S. T., & Hirata, R. D. C. (2008). mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Nakandakare ER, Neves MST, Hirata RDC. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S570 res. W070.[citado 2024 abr. 23 ]Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Nakandakare ER, Neves MST, Hirata RDC. mRA expression of SREBF1 and NPC1L1 genes in peripheral blood and mononuclear cells is modulated by simvastatin combined with ezetimibe therapy. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S570 res. W070.[citado 2024 abr. 23 ]